"A question about personalized medicine found that 88 percent of biophama executives and 84 percent of managed care respondents felt these new products will be effective. But 75 percent of patient respondents answered “no” when asked if they had heard of personalized medicine. Respondents also could not agree on what constitutes “value” in healthcare. About 38 percent of pharma executives said any definition of value must include both cost and outcomes, while just 2 percent of patients felt that way"(Thanks to MedCity News for the heads-up.)
Michael Porter, writing in the New England Journal of Medicine, proposes "A Strategy For Health Care Reform - Toward A Value-Based System." His proposals are fundamental, lucid and right-on, meaning they're sure to be opposed by some parties to the debate, the so-called "Yes, but..." crowd. Most important, in my opinion, is this: "... electronic medical records will enable value improvement, but only if they support integrated care and outcome measurement. Simply automating current delivery practices will be a hugely expensive exercise in futility. Among our highest near-term priorities is to finalize and then continuously update health information technology (HIT) standards that include precise data definitions (for diagnoses and treatments, for example), an architecture for aggregating data for each patient over time and across providers, and protocols for seamless communication among systems. "Finally, consumers must become much mor...
Comments